Question by Joel: can you take colchicine and ibuprofen at the same time for gout?

Best answer:

Answer by Hemen Ee
NO! Both of them are toxic anti-inflammatory drugs. And both of them have potential side effects on your gastrointestinal. Taking both of them together may result in serious stomach discomfort such as nausea, vomitting or diarrhea.

I wonder that it is your doctor that suggested you to take both of those drugs together or it is just your personal intention to do so due the intense gout pain you are experiencing now. What ever the reason it is, my personal experience with hundreds of gout patients tells me that is not a wise move.

Look, those drugs are just temporary relief to the pain you are suffering now. There is no instant cure for you gout problem, but there is a gradual way to get rid of the root of the problem by slowing neutralizing the uric acid crystals that are hidden in your joints or muscles. You need to be rational and shift your perspective on gout, then only you will see the ultimate way out from this gouty devil. All the best!

Add your own answer in the comments!

FDA has approved the first single-ingredient oral colchicine product. The drug, called Colcrys, is approved to treat acute gout flares and familial Mediterranean fever. Oral colchicine has been used to treat gout in the past, but until now it had not been approved by FDA. Colchicine has historically been given every hour for acute gout flares, either until the flare subsided or treatment had to be stopped because the patient developed gastrointestinal problems. But a dosing study conducted as part of the approval of Colcrys demonstrated that one initial dose and a single additional dose after one hour was just as effective and much less toxic. Healthcare professionals should use this lower recommended dosing regimen to treat acute gout flares. Healthcare professionals should also be aware that colchicine interacts with other drugs, including P-glycoprotein and strong CYP3A4 inhibitors such as cyclosporine and clarithromycin. This can lead to serious or even fatal colchicine toxicity, particularly if a patient has renal or hepatic impairment. And so concomitant use of colchicine and P-glycoprotein or strong CYP3A4 inhibitors is contraindicated in these patients. For patients with normal renal and hepatic function, consider interrupting colchicine therapy or reducing the dose if the patient needs treatment with a P-glycoprotein or a strong CYP3A4 inhibitor. FDA Patient Safety News: October 2009 For more information, please see our website: www.accessdata.fda.gov
Video Rating: 1 / 5

PHILADELPHIA — Low dose colchicine (Colcrys) appears to be as effective as high doses of the drug in reducing the pain of gout with fewer advers side effects, a researcher said here.
Video Rating: 3 / 5

talent show 07
Video Rating: 0 / 5

Although unapproved colchicine has been used for many years, FDA approved the first single-ingredient oral colchicine product, Colcrys, in July 2009 for the treatment of familial Mediterranean fever (FMF) and acute gout flares; in October 2009 Colcrys was approved for prophylaxis of gout flares (chronic gout). The approved prescribing information for Colcrys includes a new drug interaction warning, updated dosing recommendations and a medication guide. Pharmacists are reminded to dispense only FDA approved products. FDA Drug Info Rounds pharmacists discuss the differences between approved and unapproved colchicine products, concerns regarding unapproved single-ingredient oral colchicine, and how patients can offset the increased cost of Colcrys. For more information, please see our website: www.fda.gov

FDA has approved the first single-ingredient oral colchicine product. The drug, called Colcrys, is approved to treat acute gout flares and familial Mediterranean fever. Oral colchicine has been used to treat gout in the past, but until now it had not been approved by FDA. Colchicine has historically been given every hour for acute gout flares, either until the flare subsided or treatment had to be stopped because the patient developed gastrointestinal problems. But a dosing study conducted as part of the approval of Colcrys demonstrated that one initial dose and a single additional dose after one hour was just as effective and much less toxic. Healthcare professionals should use this lower recommended dosing regimen to treat acute gout flares. Healthcare professionals should also be aware that colchicine interacts with other drugs, including P-glycoprotein and strong CYP3A4 inhibitors such as cyclosporine and clarithromycin. This can lead to serious or even fatal colchicine toxicity, particularly if a patient has renal or hepatic impairment. And so concomitant use of colchicine and P-glycoprotein or strong CYP3A4 inhibitors is contraindicated in these patients. For patients with normal renal and hepatic function, consider interrupting colchicine therapy or reducing the dose if the patient needs treatment with a P-glycoprotein or a strong CYP3A4 inhibitor.
Video Rating: 5 / 5

Dr. Esther Bowie discusses new treatments for Macular Degeneration. This video is brought to you by the Medical University of South Carolina in Charleston, South Carolina. Visit www.muschealth.com to learn more about the MUSC Storm Eye Institute.
Video Rating: 4 / 5

monosodium urate crystals in tophaceous gout


Image euthman
Squash preparation of pasty white material emanating from the foot injury. compensated light microscopy polarisée.Dans this case, a podiatrist first sent a biopsy of the wound in formalin, quiet. Of course, the urate dissolved in process, and the biopsy was nondiagnostic. So I asked him to take only some of the goo, and we could smear on slide. Voila! Gotta! Note that the color of acicular crystals depends on how they are oriented to the axis of polarization.

FDA takes action against unauthorized use of a single ingredient oral colchicine
The U.S. Food and Drug Administration today took action against companies that manufacture, distribute and / or unauthorized uses of the drug colchicine market-oral single ingredient, commonly used for the prevention of leakage per day for the treatment of acute gout attacks, and for the treatment of familial Mediterranean fever (FMF).
Learn more about News-Medical Net / a>

FDA Cracks Down On not approved colchicine oral
The U.S. Food and Drug Administration (FDA) has ordered a stop marketing and has taken action against companies that manufacture, distribute and / or unauthorized use of the single market colchicine oral drug ingredient commonly used to prevent gout, treat gout, and treat familial Mediterranean fever (FMF). Companies should stop the production of single ingredient in oral colchicine …
Learn more about NewsInferno

I need to know the dose of colchicine to be taken.

good? wrong? side effects? Drop How long? How much time in each drop. I just developed gout and was perscribed but I’m having stomach reactions entrambe.grazie for your answers